rcca-header
Clinical Trials

A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs. Trastuzumab Plus Chemotherapy in the Treatment of Patients with HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment

Type of Cancer
Breast Oncology
Phase
Division (Location)
Hackensack, NJ
Study ID
NCT#
Brief Description
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs. Trastuzumab Plus Chemotherapy in the Treatment of Patients with HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.